Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Pharm Res ; 29(6): 1485-94, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22134778

ABSTRACT

PURPOSE: The aim of the present study is to evaluate the formulation effect on the oral absorption of poorly water-soluble drugs using a dissolution/permeation system (D/P system). METHODS: This D/P system, consisting of apical and basal chambers and a Caco-2 cell monolayer mounted between chambers, can be used to perform simultaneous analysis of drug dissolution and permeation process of drugs applied as various dosage forms. Oral administration study with rats was also performed for both drugs as the same dosage forms. RESULTS: When danazol, a low-soluble and high-permeable drug, was applied to the D/P system as various formulations, dissolved and permeated amounts were significantly high compared with those from a suspension form. On the other hand, whereas the dissolved amount of pranlukast, a low-soluble and low-permeable drug, was significantly increased by formulations, there were no significant changes observed in the permeated amount between suspension and formulation. The oral availability of danazol was significantly increased by formulations but not pranlukast, which corresponded well to in vitro evaluations. CONCLUSION: These results indicated that the D/P system might be applicable for selection of formulation on the basis of physicochemical drug properties.


Subject(s)
Chromones/administration & dosage , Chromones/pharmacokinetics , Danazol/administration & dosage , Danazol/pharmacokinetics , Intestinal Absorption , Intestinal Mucosa/metabolism , Administration, Oral , Animals , Caco-2 Cells , Chemistry, Pharmaceutical , Chromones/blood , Chromones/chemistry , Danazol/blood , Danazol/chemistry , Drug Compounding , Humans , Male , Permeability , Rats , Rats, Wistar , Solubility , Technology, Pharmaceutical/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...